FindTrial
Sign In

Optimized Administration of Voriconazole and Therapeutic Drug Monitoring in Children and Adolescents: a Single-Centre Retrospective Experience from China

Optimized Administration of Voriconazole and Therapeutic Drug Monitoring in Children and Adolescents: a Single-Centre Retrospective Experience from China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025821
Enrollment
Unknown
Registered
2019-09-09
Start date
2019-09-16
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal infection in children

Interventions

Case Series:voriconazole

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children patients aged <= 18 years who was administered voriconazole enterally or parenterally and monitored at least one voriconazole plasma trough concentration was eligible for study from 1th January 2016 to 31th December 2018.

Exclusion criteria

Exclusion criteria: The source of voriconazole TDM blood sampling was from the outpatient department, incomplete medical record information and body weight of >= 50 kg when patients aged 12 to 14 years.

Design outcomes

Primary

MeasureTime frame
Blood concentration;—

Countries

China

Contacts

Public ContactYan Miao

The Second Xiangya Hospital of Central South University

yan.miao@126.com+86 13787783668

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026